SWOG clinical trial number
SWOG-9338
A Phase II Trial of Combination Therapy With 5-Fluorouracil, a-Interferon and Interleukin-2 ("FUNIL") for Advanced Renal Cell Carcinoma
Closed
Phase
Accrual
100%
Published
Abbreviated Title
Advanced Renal
Activated
12/15/1994
Closed
09/01/1997
Research committees
Genitourinary Cancer
Publication Information Expand/Collapse
2000
Infusional interleukin-2 and 5-fluorouracil with subcutaneous intergeron-a for the treatment of patients with advanced renal cell carcinoma: A Southwest Oncology Group phase ll study.
1999
Infusional interleukin-2 and 5-fluorouracil with subcutaneous interferon-a for advanced renal cell carcinoma. A Southwest Oncology Group study.
Other Clinical Trials
SWOG Clinical Trial Number
S2210
S2210, "Targeted Neoadjuvant Treatment for Patients with Localized Prostate Cancer and Germline DNA Repair Deficiency"
Research Committee(s)
Genitourinary Cancer
Activated
08/14/2023
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
S2200
S2200, A Phase II Randomized Trial of Cabozantinib with or Without Atezolizumab in Patients with Advanced Papillary Renal Cell Carcinoma: PAPMET2
Research Committee(s)
Genitourinary Cancer
Activated
09/19/2022
Accrual
10%
Open
Phase
SWOG Clinical Trial Number
CTSU/A031901
Duration of Immune Checkpoint Therapy in Locally Advanced or Metastatic Urothelial Carcinoma: A Randomized Phase 3 Non-Inferiority Trial
Research Committee(s)
Genitourinary Cancer
Activated
05/01/2021
Open
Phase